Cipla unit recalls anti-epileptic drug in US over pouch leakage issues

Cipla, in a regulatory filing, said InvaGen Pharmaceuticals is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP (500 mg), at the consumer level due to seal integrity issues, allowing for powder leakage from the pouch

Related Keywords

United States ,Chhattisgarh ,India ,Mumbai ,Maharashtra , ,Invagen Pharmaceuticals ,Cipla ,Invagen Pharmaceuticals Inc ,Oral Solution ,Vishnu Deo Sai ,Chief Minister ,Dhiraj Sahu ,Xgen Pharmaceuticals ,Anti Epileptic Drug ,Vigabatrin For Oral Solution ,Pouch Leakage Issues ,